Fraxidin

CAS: 525-21-3

Ref. 3D-FF65859

Produktinformation

• Name: Fraxidin
• Synonyme: 6,7-Dimethoxy-8-hydroxycoumarin, 2H-1-Benzopyran-2-one, 8-hydroxy-6,7-dimethoxy-, 8-Hydroxy-6,7-dimethoxy-2H-1-benzopyran-2-one, 8-hydroxy-6,7-dimethoxy-2H-chromen-2-one, Coumarin, 8-hydroxy-6,7-dimethoxy-, 8-Hydroxy-6,7-dimethoxy-2-benzopyrone

Beschreibung

Fraxidin is a coumarin derivative that has been used as an antidiabetic agent in China. It has been shown to have glucose-lowering effects by inhibiting the activity of gluconeogenic enzymes, such as glycogen phosphorylase and fructose-1,6-bisphosphatase. Fraxidin also inhibits hepatic steatosis by regulating the expression of genes involved in lipid metabolism. This compound may also have potential for treating autoimmune diseases.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 222.19 g/mol
• Formel: C₁₁H₁₀O₅
• Reinheit: Min. 98 Area-%
• Farbe/Form: Powder
• InChl: InChI=1S/C11H10O5/c1-14-7-5-6-3-4-8(12)16-10(6)9(13)11(7)15-2/h3-5,13H,1-2H3
• InChI Key: InChIKey=QNFBKOHHLAWWTC-UHFFFAOYSA-N
• SMILES: COc1cc2ccc(=O)oc2c(O)c1OC